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  1Executive Summary: 
 
Currently established methods of tissue preservation for heart transplantation involve placing the 
harvested donor heart in a cold, nutrient-rich cardioplegic solution. Clinically, methods like these 
have only been shown to preserve heart tissue for a matter of hours. A new solution for tissue 
preservation developed by Transmedics Inc involves placing the heart in a chamber that mimics 
the physiological conditions of the human chest cavity. This solution maintains the heart in a 
beating state and pumps blood and nutrients through the myocardial circulation. This 
preservation technique has been clinically shown to improve the length of time that a heart can 
be preserved ex-vivo and when properly implemented, could theoretically preserve a donor heart 
indefinitely.  
 
A computer simulation using Finite-Element analysis was performed with the intention of 
comparing how well these two methods work to perfuse heart tissue with oxygen over a long 
period of time. As expected, it was shown that the Transmedics cart could keep the concentration 
of oxygen in the heart tissue at optimal levels indefinitely while the immersion technique could 
only keep the concentrations of oxygen in the tissue above healthy levels for around 5.5 hours. 
Investigations into the effect of temperature on each preservation technique found that the 
Transmedics preservation is most effective at 37 degrees Celsius, body temperature; while the 
immersion technique is most effective at 4 degrees Celsius. Though the Transmedics device was 
shown to be far superior in many areas, other considerations, like the cost and the ease of 
implementation of each technique have lead us to conclude that there are still certain situations in 
which tissue preservation by cooling is the best option for heart transplantation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  2Introduction: 
 
In heart transplantation, one of the most important factors for success of the process is the 
transport of the heart itself. Hearts have a high rate of failure during transport due to very basic 
transport systems that do not realistically mimic the physiologic conditions in the body. Our goal 
is to model two systems of heart transport that keep the heart alive in different ways. From these 
models we can draw conclusions as to which method is most effective. The first method uses a 
more primitive design involving submerging the heart in a nutrient bath while the second 
involves introducing an artificial coronary blood supply where the oxygen and nutrients are 
delivered in a more physiologically correct manner. If our model proves one method to be more 
effective, it could ultimately allow for a greater success rate of heart transplantation.  
 
We are concerned with heart viability ex vivo when being transported for transplant.  Standard 
procedure currently involves cooling the heart in a nutrient-rich fluid while it is outside of the 
body.  However, during this process the heart still slowly decays.  It has been shown that keeping 
the heart at body temperature and providing it with the necessary nutrients can mimic in vivo 
conditions and keep the heart in a healthier state.  This requires pumping fluid through the 
coronary arteries to the cells of the heart.  We wish to study the efficacy of these two methods of 
heart preservation. 
  
We anticipate that the immersion solution will not be better the new procedure, but it would be 
more economical.  For this reason, even if this method of nutrient delivery should prove 
insufficient on the scale of the human heart, it may still suffice on other smaller scales for 
laboratory experimentation. It is also possible that the immersion solution can be optimized to 
keep the heart alive for a longer amount of time by investigating the effect that temperature has 
on tissue preservation. 
 
For each of these heart preservation methods different models are required.  When pumping fluid 
through the heart the oxygen will diffuse through capillary walls - we will model this as an 
axisymmetric cylinder of tissue surrounding a capillary.  When suspending the heart in a 
nutrient-rich fluid - we will model the heart as a rectangular 2-D slab with constant concentration 
boundary conditions along the edges.  For this study, we will limit ourselves to investigating the 
diffusion of oxygen in the tissue.   
 
 
 
 
 
 
 
 
 
 
 
 
 
  3Objectives: 
 
By looking at the concentration profiles of oxygen in the tissue over time we can discern the 
efficacy of each method in the following ways: 
   
●  Determine how long each method can keep oxygen levels above the minimum for cardiac 
tissue survival at all points in the tissue.   
 
●   If the concentration never drops to the minimum we wish to see how long it takes for the 
average concentration of the tissue to reach optimal conditions for each method. 
 
Sensitivity analysis for the effect of lowering the temperature of the tissue will be performed to 
investigate the feasibility of each method at a reduced temperature. As an alternative, non-
computational means of comparison, we will also consider the economics and feasibility of 
implementing each method. 
 
Geometry and Design Schematics: 
 
Diffusion in the capillaries will be assumed to be axisymmentric: 
 
 
 
 
 
 
 
 
 
The Tissue Being 
Analyzed 
Tissue radius (1/2 
avg. distance 
between capillaries 
in the heart) = 12µm 
The Capillary wall 
thickness = 1µm  
Axis of 
Symmetry 
Capillary radius = 2µm. 
Concentration specified 
at the capillary wall 
 
 
 
 
 
 
  4Diffusion by immersion will be modeled as a 2-D slab with its thickness equal to the thickest 
part of the heart wall (the part of the heart where it will be hardest to keep the nutrients at 
acceptable levels):   
 
 
The outer edge of the heart 
will be resting in a solution 
of nutrients, and we will 
have diffusion into the 
tissue 
 
The Tissue Being 
Analyzed 
This is the inner cavity of the heart which 
will also be full of fluid that has the same 
concentrations as the external fluid   
 
 
 
 
 
 
Thickest portion 
of the heart: 
11mm 
 
 
 
 
 
 
 
 
Note: These two methods of heart preservation will be called the ‘Immersion’ and 
‘Capillary/Perfusion’ methods in the following sections of the paper. 
 
Capillary Mesh: 
 
As figure 1 below shows, we created a mesh that was tighter as it got closer to the capillary wall.  
This was done because the changes in concentration are greater near the capillary and a finer 
mesh was needed to accurately visualize these changes in concentration.  During testing we 
varied the density of the mesh to ensure that it was not affecting our final results. We found  
indeed the solution due to the mesh had converged.   
 
Figure 1:  Visual of the mesh with node numbers for the capillary.  The bottom of the screen is 
the edge of the capillary wall while the top of the screen is the middle of the tissue 
between two capillaries.   
 
 
 
 
 
 
 
 
 
 
 
 
  5Immersion mesh: 
 
Again, as figure 2 below shows, we used a tighter mesh at the edge of the heart where the tissue 
interacted with the nutrient bath.  The nutrients at the wall undergo a larger gradient, and in turn 
the finer mesh is needed to obtain accurate results at this location.  As shown later, we varied the 
testing to show that our solution converged for this mesh density, validating figure 2 as the mesh 
used for our solutions.   
 
Figure 2:  Visual of the immersion mesh with node numbers.  The bottom of the screen is the 
edge of the heart in contact with the nutrient bath while the top of the screen is the 
middle of the tissue between the inner and outer walls of the heart.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  6Capillary Solutions: 
 
In heart transplantation, we are interested in preserving all of the tissue.  In turn we need to look 
at the tissue that gets the least nutrients, the section of the mesh that is furthest away from the 
capillary.  This area is essentially the ‘weakest link.’ If we know the furthest tissue has adequate 
nutrients, then we know the rest of the tissue also has enough nutrients.  We chose to analyze 
node 55 for this purpose, which you can see on the top of figure 1.  Figure 3 below shows 
concentration of oxygen against time at this node. 
 
Figure 3:  Concentration of oxygen verse time for node 55 over the course of 3 seconds.   
 
 
As you can see in figure 3, the concentration rapidly increases, and is at its maximum 
concentration very shortly.  Within one second, the concentration of oxygen has reached steady 
state levels and would theoretically remain there indefinitely.  This graph basically shows that 
the capillaries are extremely effective in the diffusion of oxygen to surrounding tissue.  In order 
to more closely see what happens initially, look at figure 4 on the next page to ‘zoom’ into the 
first second of blood flow.   
 
 
 
 
 
 
 
 
 
 
 
 
  7Figure 4:  Concentration of oxygen verse time for node 55 over the course of 1 second.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As figure 4 shows, the concentration takes about half a second to reach maximum levels, which 
is extremely fast.  Pumping blood through the capillaries effectively eliminates the oxygen 
deficiency problem.  We also created a contour plot for the entire mesh at about 1 second after 
the start of blood flow, which shows how node 55 is the last to receive the needed oxygen.  This 
is seen in figure 5 below. 
 
Figure 5:  Contour plot of the concentration of oxygen in the capillary wall and cardiac tissue 
 
  8Immersion Solutions: 
 
We initially considered the case where the heart is in a solution at body temperature. First 
metabolic rates for normal beating hearts were used. For this case, apart from areas very close to 
the edge, the entire heart was below our minimum specified concentration of oxygen within 2.5 
minutes.   
 
It was found that by using a cardioplegic solution to arrest the heart, the oxygen consumption can 
be reduced by up to 75% even at body temperature. Using a new metabolic rate, we reran the 
experiment for four times as long and found an improvement in the amount of oxygen delivered.  
However there was still no oxygen diffusion reaching the middle of the heart. 
 
Figure 6: Comparison of oxygen concentrations at various points in the heart.  The red bars 
show the concentration for a normal, arrested heart after 600 seconds, while the blue bars show 
the concentration for a normal, beating heart after 150 seconds.   
[O2] for a beating and arrested heart
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Note: Node 337 is approximately 0.5 cm from the heart wall, 347 is 1 cm and 350 is 2 cm. 
 
Since this was insufficient to protect the heart from damage, we investigated the effects of 
lowering the temperature reducing the metabolism of oxygen in the tissue.  This is included in 
the sensitivity analysis section. 
 
 
 
  9Sensitivity Analysis 
 
We investigated the effect that varying several critical variables used in the software had on our 
solution. These include a temperature, initial conditions and the boundary conditions.   
Temperature has an effect on the diffusivity of oxygen in the tissue and also on the consumption 
rate of oxygen in the tissue. For our purposes, in both the immersion and capillary preservation 
techniques, temperature and other variables should be optimized in order to maximize the 
concentration of oxygen in the tissue.  The following gives our range of reasonable variations in 
parameters: 
 
Oxygen Concentration in the Blood: 
 
The saturation of hemoglobin is related to the partial pressure of oxygen.  Air at sea level is 
normally 21% oxygen, giving a partial pressure of 100mm Hg, and in turn a concentration of 
233ml oxygen per liter of blood.  With pure oxygen, and 100% saturation, the concentration only 
rises slightly to 239ml oxygen per liter of blood.  At high altitudes blood has a low partial 
pressure of 40mm Hg, and in turn a 42% saturation, correlating to 96ml oxygen per liter of 
blood.   
 
Due to the above data, we feel an accurate range to test the oxygen concentration is a normal 
value of 233 ml O2/L blood, a minimum of 96 ml O2/L blood, and a maximum of 239 ml O2/L 
blood.  Converting these values to kg O2/L blood we have a normal value of 3.34*10
-4 kg O2/L 
blood, a minimum of 1.37*10
-4 kg O2/L blood, and a maximum of 3.42*10
-4 kg O2/L blood 
 
Initial Concentration of Oxygen in Tissue: 
 
The normal concentration of oxygen in healthy heart tissue is 2.6*10
-4 kg O2/L tissue.  If the 
concentration drops below 3.7*10
-5 kg O2/L tissue there is tissue death, resulting in an unviable 
heart for transplant.  In our computations we are assuming a fast and efficient harvesting of the 
heart, and in turn having an initial concentration at the optimal level.  For the sensitivity analysis 
we are comparing the results to a heart where the concentration has dropped down to the 
minimum concentration of 3.7*10
-5 kg O2/L tissue and the intermediate value of 1.5*10
-4 kg 
O2/L tissue.   
 
Diffusion and Consumption of Oxygen in Tissue Due to Temperature: 
 
Myocardial oxygen consumption was found to be directly related to systemic temperature during 
cardiac arrest, with the formula Y=-0.3 x X +1.10 x X(2)-0.02 x X(3) (Y, myocardial oxygen 
consumption; X, rectal temperature; R(2)=0.533; P<0.0001) fitting the data collected clinically.  
Using this relationship, we were able to determine the effect of temperature on metabolic rate for 
our model. This is graphically represented below for a reasonable range of temperatures for 
cardiac preservation. 
 
 
 
 
  10Figure 7: Plot showing how the consumption rate of oxygen depends on temperature 
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Other information was found relating the effect of temperature on the diffusivity of oxygen in 
mammalian muscle. A temperature
 coefficient of 4.60%/degrees C was found relating diffusivity 
of oxygen in the tissue to temperature, for a reasonable range of temperatures (between 11 and 
37 degrees C). Using this relationship and known diffusivities at 11 and 37 degrees, values for 
diffusivity across the temperature range were linearly interpolated as shown below. 
 
Figure 8: Plot showing how the diffusion of oxygen depends on temperature 
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  11Based upon the information on the previous page, the effect of the temperature of the tissue was 
investigated across a reasonable range, between 4 and 37 degrees Celsius.  Tissue death occurs at 
-20 Celsius, so the values that we looked at are within a practical range.   
 
In addition, two diffusivity values were found in the literature for 37 degrees C. The effect of 
varying the diffusivity at this temperature was investigated. A diffusivity of 2.4 x 10
-9 m
2/s was 
used by the authors who found the temperature dependence of the diffusivity of oxygen in tissue 
so for our temperature sensitivity analysis, the other diffusivities were calculated from this value. 
 
Mesh Convergence: 
 
In order to minimize discretization error, we performed a thorough check to see whether the 
resolution of our mesh was sufficient. We generated plots showing how the solution was affected 
by the number of nodes in the mesh to check that it had converged. We confirmed that our 
solution was independent of the mesh resolution. This convergence can be seen in Appendix B. 
 
 
 
  12Capillary Sensitivity Analysis: 
 
In the design of a preservation technique or device - temperature is an easily controlled variable 
that can effect the concentration of oxygen in living tissue. The effect of temperature on the 
solution to the capillary preservation method was investigated, incorporating changes in 
diffusivity and consumption rate. The results for a range of reasonable temperatures are 
presented below. Generally speaking, a temperature should be chosen which results in the 
greatest concentration of oxygen in the tissue. Using this basis, it appears that the tissue is most 
fully perfused with oxygen at 37 degrees celcius, body temperature. 
 
At this scale, it appears that the diffusivity of the tissue dominates over the metabolic 
consumption of oxygen. That is, though the metabolic consumption is less at lower temperatures, 
the diffusivity is also diminished. Since the concentration of oxygen in the tissue is the least at 
lowest temperatures, we can conclude that at this scale the effect of temperature on diffusion is 
more important in this case than its effect on metabolism. 
 
Figure 9: Effect of temperature on final results for the capillary solution 
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Other parameters that can be realistically controlled in the design of a cardiac preservation 
technique or device are the concentration of oxygen in the blood and the concentration of oxygen 
in the heart before it is preserved (after harvesting). The effect of varying these conditions was 
investigated for a reasonable range of values.  
 
 
 
 
 
 
  13It appears that the initial condition of the heart has relatively little effect on the efficacy of 
preservation for the capillary method - assuming that none of the tissue has died. As expected, it 
also appears that the best concentration of oxygen in the blood for preservation is the fully 
saturated case, but it does not appear to be significantly better than the natural physiological 
condition. 
 
Figure 10: Effect of realistic variation in initial conditions and boundary conditions on final 
results for the capillary solution 
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  14Immersion Sensitivity Analysis:  
 
Realistically speaking, the immersion preservation technique would not practically be 
implemented at body temperature because of the relatively high levels of oxygen consumption at 
this temperature. Donor hearts are typically immersed in a cardioplegic solution at or near zero 
degrees Celcius - at this temperature diffusivity of the tissue is reduced, but the metabolism of 
oxygen is also signifcantly reduced. When implementing the immersion preservation technique, 
temperature can be easily controlled. Sensitivity analysis was performed to optimize the 
concentration of oxygen in the cardiac tissue for a realistic range of temperatures and their 
respective diffusivities and metabolic rates. 
 
Figure 11: Effect of temperature on final results for the immersion method 
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Tissue Death
The figure above shows that for the immersion preservation technique, lower temperatures more 
effectively keep the cardiac oxygen concentration levels above the level of tissue death than 
higher temperatures; this is consistent with our expectations. We can conclude that for this 
situation, at the larger scale - reducing the metabolic oxygen consumption is more important than 
keeping the diffusivity of oxygen at a high level. For the most part, the diffusion of oxygen from 
the edges of the heart wall never reaches the center of the heart in a practical amount of time. 
When this simulation was run for longer periods of time at four degrees Celcius, it was found 
that the immersion solution could keep the heart tissue viable for approximately 5.5 hours. 
 
 
 
  15Figure 12: Effect of initial condition on final results for the immersion method 
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Figure 13: Effect of boundary condition on final results for the immersion method 
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  16As illustrated in the figures above, the effect of varying the initial concentration and the 
boundary condition was investigated. For our solution we initially assumed perfect harvesting of 
the donor heart, in which the concentrations of oxygen in the tissue are at optimal levels when 
the tissue is placed in the preservation device.  If however, the initial concentration of oxygen 
had been allowed to drop slightly before placing in the solution, the effects are seen in the graph 
of initial concentrations.  Initial concentration is key in the immersion solution because the 
diffusion is so limited so efficient harvesting and placing in cardioplegic solution on ice would 
be crucial. 
 
In the case where the solution surrounding the hard were to have higher or lower concentration 
of oxygen, there is also a noticeable effect, higher than expected farther away from the heart 
wall.  Therefore it would also be very important to keep the oxygen concentration in the solution 
as high as possible to maximize the health of the tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  17Conclusion and Other  Considerations: 
 
Our computational model showed that the Transmedics cart, in which the heart is maintained at 
body temperature and blood is pumped through the capillaries, is extremely effective at perfusing 
the cardiac tissue with oxygen. From the start of preservation, it took less than a second for the 
concentration of oxygen in the tissue to match the concentration of blood pumped through the 
capillaries.  
 
The other technique, in which the heart is placed in a cold cardioplegic solution showed a slow 
decay of oxygen as it was metabolized by the tissue. This metabolic consumption can be reduced 
by lowering the temperature of the solution to 4 degrees Celcius without many problems, since 
oxygen never really diffuses fully into the heart wall. Under these conditions our model showed 
heart viability for around 5.5 hours.  
  
Extensive research went into this project in order to come up with accurate values for the various 
parameters used.  However, the literature available was not always consistent and is not 
necessarily accurate.  Much of our data did not come directly from studies dealing with heart 
tissue preservation, many of our parameters instead came from studies on cardiac bypass 
surgery, where the heart is temporarily cut-off from blood circulation. To ensure that our 
conclusions are valid, we conducted the sensitivity analysis which showed that our results are 
minimally effected even if the parameters are slightly off.  We also assumed that there was a 
constant concentration at the capillary wall for the perfusion method.  Since red blood cells are 
only slightly smaller than the capillaries in myocardial circulation, the momentum equation 
would be not apply. However, a constant concentration is not completely accurate.  There is not 
a continuous line of red blood cells going through capillaries; instead there are spaces between 
them. The concentration of oxygen at the capillary wall is likely to vary with the rate of red 
blood cells traveling through the capillary at a given time.  This is something that needs to be 
taken into consideration when finalizing a device such as the Transmedics cart, yet we feel it 
does not contribute significantly to error in our solution  
 
A large part of our project was analyzing the effect of temperature on the ability to preserve the 
heart when considering oxygen consumption.  While the cooling of the heart does make the 
immersion method more successful by reducing metabolic consumption of oxygen, it would also 
be important to look into any harmful effects the cold temperature could have.  It is likely that 
holding the temperature of the tissue at body temperature  is far less damaging since this 
situation more realistically mimics the physiologic condition of the chest cavity (as in the 
Transmedics cart). Additionally, we only looked at the diffusion of oxygen in cardiac tissue.  
There are many more nutrients involved in the maintenance of the heart which are important to 
survival that should be investigated.  These could also be affected by cooling and/or warming the 
heart tissue. 
 
It is important to note that the Transmedics device is not yet available for commercial use and 
that when it is, it is sure to be expensive.  In most cases, the perfusion method discussed may be 
the best option, but perhaps not economically.  Building a device like it is obviously no simple 
matter.  Some things that must be taken into consider for production are: creating a long lasting, 
efficient and reliable battery supply; configuring electric impulse nodes for activating the 
  18pumping action of the heart; finding a pump capable of pushing blood through the filter system; 
using an oxygen tank for higher diffusion rates; using biomechanical piping that can be attached 
to veins / arteries without causing damage or loss of blood flow; and creating a fast acting filter 
capable of removing waste from cellular respiration and  other build up.  All these things are 
vital to the production of heart pump, and each one adds another set of variables necessary to 
understand and control.  For example, hooking up piping to the coronary artery in the heart may 
require special training for paramedics – introducing further added costs.  Further, when such a 
device does become commercially available, the costs will be quite high until production is 
undertaken on a larger scale.  
 
No product is worth selling that doesn’t make a company money, and although it was difficult to 
estimate the costs associated with many of the necessary parts of such a machine, we decided to 
look at the next best option as way of gauging what the cost might be.  Hearts are obviously a 
valuable commodity.  Currently heart transplants cost anywhere between $75,000 and $125,000.  
If the perfusion device were able to allow for the survival of even a single heart, as we predict it 
will be able to, then it will be of considerable economic benefit to the hospital that operates it.  
Furthermore, such a device could potentially be used for other organ transplants like kidneys.  
Roughly speaking, this machine will probably cost between $50,000 and $150,000 to make 
(depending upon production levels), and will likely be sold for between $100,000 and $250,000.  
There is obviously quite a bit of uncertainty associated with such an estimate.  External factors 
like how well such a machine performs in the field, its functionality in other areas of 
medicine/research, and demands from hospitals could largely impact the cost of production. 
 
The demand of hearts for transplant is extremely high compared to the supply, and in turn money 
isn’t as much of a consideration as usual.  Because of this, the Transmedics device will most 
likely become prevalent among major hospitals that more frequently take out hearts for 
transplantation.  It is likely that the large need for hearts will offset the high cost of the necessary 
equipment.  Cooling of the entire heart is the current method of heart preservation, and while it is 
inferior to the perfusion method employed by the Transmedics device, it is far easier to 
implement only requiring cold cardioplegic solution. Transmedics preservation requires the use 
of a complicated device, hooking up the myocardial circulation of the heart, and constant 
monitoring of the tissue condition based on what fluids are being pumped through.  It is not 
likely that the Transmedics device will be used outside of large hospitals and special heart 
transportation services.  The common ambulance, doctor’s office, etc, will most likely not have 
the capacity to use the Transmedics device in the near future.   
 
During research involving smaller animal hearts, currently, hearts are often just left out to sit 
while the experiment takes place.  We did not specifically investigate a scaling effect, but we did 
notice that for the small-scale case (the capillary solution), diffusion of oxygen in the tissue 
tended to be more important than the metabolic consumption of oxygen; while in the large scale 
case (the immersion solution), the opposite was true. Thus, the cooling technique may be more 
effective for smaller geometries where diffusion can reach all of the tissue. Our results show that 
at the very least, cooling a smaller heart could improve the survival of the heart during 
experimentation. A cheaper device, similar to the Transmedics unit, could also be designed for 
use specifically in animal research.  Such a device could expand the research capabilities of 
scientists at a reasonable cost, and instability of the tissue would be less of a concern.   
  19Appendix A: 
 
Governing Equations: 
 
Equation for capillary diffusion using cylindrical coordinates: 
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Equation for diffusion in blood bath: 
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Note: for both of these scenarios there is no bulk flow, so that term was eliminated for the 
equations 
 
Non-Dimensionalization: 
 
As mentioned earlier, the radius of a section of capillary tissue is around 12 micrometers - this 
scale was far too small for computer implementation so we used a non-dimensionalized form of 
the Diffusion equation for the capillary solution: 
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The characteristic length, Lo was arbitrarily chosen to be 10
-3 m and the characteristic Diffusivity 
constant was chosen to be 2.4E-9 m
2/s, the diffusivity of oxygen in the tissue at 37 degrees C. 
 
Boundary Conditions and Essential Information: 
 
For capillary diffusion: 
 
●  Concentration of oxygen at capillary wall (concentration of solution) =  0.334 g O2/L 
blood 
●  Initial concentration of oxygen in the tissue = 0.26 g O2/L tissue 
●  Rate of metabolic consumption of oxygen in the tissue = 129.6 μg O2/ g tissue/ min 
●  Rate of diffusion of oxygen through the capillary wall = 2.4*10
-5 cm
2/s  
●  Rate of diffusion of oxygen through the cardiac tissue = 2.4 * 10
-5 cm
2/s 
●  Flux on all sides except capillary wall = 0   
●  Flux at center of the capillary = 0 (because axi-symmetric) 
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●  Concentration of oxygen at heart wall (concentration of solution) =  0.334 g O2/L  
●  Initial concentration of oxygen in the tissue = 0.26 g O2/L tissue 
●  Rate of metabolic consumption of oxygen in the tissue (beating heart) = 129.6 μg O2/ g 
tissue/ min 
●  Rate of metabolic consumption of oxygen in the tissue (arrested heart) = 32.4 μg O2/ g 
tissue/ min 
●  Rate of diffusion of oxygen through the cardiac tissue = 2.4 * 10
-5 cm
2/s 
●  Flux at the center of the heart = 0   
 
General Information: 
 
●  Minimum concentration of oxygen for tissue survival =  0.037 g O2/L tissue 
●  Optimal (normal) concentration of oxygen in tissue  = 0.26 g O2/L tissue 
 
 
Nondimensionalized Variables for Capillary Solution: 
Variable  Def’n  Value (Dimensional)  Value (Non-Dim) 
Diffusivity capillary 
wall (37°) 
D1/D 2.4E-9  m
2/s 1.0 
Diffusivity cardiac 
tissue (37°) 
D2/D 2.4E-9  m
2/s 1.0 
 
Metabolic consumption 
of oxygen (37°) 
R/(D/Lo)
2 5.40E-07 kg O2/ 
            (L tissue*s) 
9.375E4 
Duration of the 
simulation 
(td*D)/Lo
2 3s 7.413E-3 
Time step  (tt*D)/Lo
2 0.1s 2.471E-4 
Capillary Tissue Radius  L/Lo 12E-6 m  0.012 
 
 
Calculations: 
Metabolic consumption = 129.6 μg O2/ g tissue/ min * 1 min/60 s * 1 kg/ 10
9 μg  * 1000 g / L =  
2.16E-06 kg O2/L tissue 
 
For paraplegic situation: 2.16E-06 kg O2/ L tissue * 25% = 5.4E-07 
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Capillary .FIINP File: 
/ 
/  INPUT FILE CREATED ON 03 May 06 AT  18:57:31 
/ 
/ 
/ ***  FICONV Conversion Commands ***  
/ ***  Remove / to uncomment as needed 
/ 
/  FICONV(NEUTRAL,NORESULTS,INPUT) 
/  INPUT(FILE= "cpllry.FDNEUT") 
/  END 
/  *** of FICONV Conversion Commands 
/ 
TITLE 
 
/ 
/ ***  FIPREP  Commands *** 
/ 
FIPREP 
 PROB (AXI-, ISOT, NOMO, TRAN, LINE, FIXE, NEWT, INCO, SPEC = 1.0) 
 PRES (MIXE = 0.100000000000E-08, DISC) 
 EXEC (NEWJ) 
 SOLU (S.S. = 50, VELC = 0.100000000000E-02, RESC = 0.100000000000E-01, 
       SCHA = 0.000000000000E+00, ACCF = 0.000000000000E+00) 
 TIME (BACK, FIXE, TSTA = 0.000000000000E+00, TEND = 0.741300000000E-02, 
       DT = 0.247100000000E-03, NSTE = 100) 
 OPTI (SIDE) 
 DATA (CONT) 
 PRIN (NONE) 
 POST (RESU) 
 SCAL (VALU = 1.0) 
 ENTI (NAME = "Capillary Wall", SOLI, PROP = "mat1", SPEC = 1.0, 
       MDIF = "C1_Capillary Wall", MREA = "C1_Capillary Wall") 
 ENTI (NAME = "Tissue", SOLI, PROP = "mat2", SPEC = 1.0, MDIF = "C1_Tissue", 
       MREA = "C1_Tissue") 
 ENTI (NAME = "Wall Bottom", PLOT) 
 ENTI (NAME = "Tissue Bottom", PLOT) 
 ENTI (NAME = "Tissue End", PLOT) 
 ENTI (NAME = "Tissue Top", PLOT) 
 ENTI (NAME = "Wall Top", PLOT) 
 ENTI (NAME = "Wall Edge", PLOT) 
 ENTI (NAME = "Capillary Edge", PLOT) 
 DIFF (SET = "C1_Capillary Wall", CONS = 1.0) 
 DIFF (SET = "C1_Tissue", CONS = 1.0) 
 REAC (SET = "C1_Capillary Wall", TERM = 1, KINE) 
  -0.5900000000E-03,  0.3100000000E+03,  0.0000000000E+00,  0.1000000000E+01, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00 
 REAC (SET = "C1_Tissue", TERM = 1, KINE) 
  -0.5900000000E-03,  0.3100000000E+03,  0.0000000000E+00,  0.1000000000E+01, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
  22   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00, 
   0.0000000000E+00,  0.0000000000E+00,  0.0000000000E+00 
 BCNO (SPEC = 1.0, CONS = 0.334000000000E-03, ENTI = "Capillary Edge") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "Wall Bottom") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "Tissue Bottom") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "Wall Top") 
 ICNO (SPEC = 1.0, CONS = 0.260000000000E-03, ALL) 
 EXTR (ON, AFTE = 5, EVER = 5, ORDE = 3, NOKE, NOFR) 
END 
/  *** of FIPREP Commands 
CREATE(FIPREP,DELE) 
CREATE(FISOLV) 
PARAMETER(LIST) 
 
Problem Statement Keywords: 
PROB (AXI-, ISOT, NOMO, TRAN, LINE, FIXE, NEWT, INCO, SPEC = 1.0) 
 
Descriptor Value  Explanation 
Geometry Type  AXISYMMETRIC  System is symmetric about 
an axis 
Temperature Dependence  ISOTHERMAL Constant  temperature 
system 
Flow Type  NO MOMENTUM  No bulk flow 
Simulation Type  TRANSIENT  Solution is time dependent 
Convective Term  LINEAR  No convective term 
Surface Type  FIXED  Surface is fixed 
Fluid Type  NEWTONIAN  Fluid can be considered 
Newtonian 
Flow Regime  INCOMPRESSIBLE  Fluids are incompressible 
Species Dependence  SPECIES=1  Species present  
 
 
 
Solution Statement Keywords: 
SOLU (S.S. = 50, VELC = 0.100000000000E-02, RESC = 0.100000000000E-01, 
       SCHA = 0.000000000000E+00, ACCF = 0.000000000000E+00) 
 
Descriptor Value  Explanation 
Solution Method  Successive Substitution = 
50 
Maximum number of 
iterations  
Velocity Convergence  .1e-02  Velocity convergence 
tolerance 
Residual Convergence  .1e-1  Residual vector 
convergence tolerance 
Solution Change  0  Default percentage change 
in solution magnitude 
Relaxation Factor  ACCF = 0  For acceleration of 
convergence 
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Time Integration Keywords: 
TIME (BACK, FIXE, TSTA = 0.000000000000E+00, TEND = 0.741300000000E-02, 
       DT = 0.247100000000E-03, NSTE = 100) 
 
Descriptor Value  Explanation 
Time Integration  BACKWARD  FIDAP uses implicit 
method (t + ∆t) 
Time Step Algorithm  FIXED  Time step is constant 
Start Time  0  Our problem starts at t = 0s 
End Time  0.007413  Our problem ends at t = 3s 
Time Step  0.0002471  Time increment is 0.1s 
Number of Time Steps  100  There are 100 fixed time 
steps 
 
 
Immersion FIINP File: 
/ 
/  INPUT FILE CREATED ON 03 May 06 AT  20:32:07 
/ 
/ 
/ ***  FICONV Conversion Commands ***  
/ ***  Remove / to uncomment as needed 
/ 
/  FICONV(NEUTRAL,NORESULTS,INPUT) 
/  INPUT(FILE= "heart.FDNEUT") 
/  END 
/  *** of FICONV Conversion Commands 
/ 
TITLE 
 
/ 
/ ***  FIPREP  Commands *** 
/ 
FIPREP 
 PROB (2-D, ISOT, NOMO, TRAN, LINE, FIXE, NEWT, INCO, SPEC = 1.0) 
 PRES (MIXE = 0.100000000000E-08, DISC) 
 EXEC (NEWJ) 
 SOLU (S.S. = 50, VELC = 0.100000000000E-02, RESC = 0.100000000000E-01, 
       SCHA = 0.000000000000E+00, ACCF = 0.000000000000E+00) 
 TIME (BACK, FIXE, TSTA = 0.000000000000E+00, TEND = 20000.0, DT = 2.0, 
       NSTE = 10000) 
 OPTI (SIDE) 
 DATA (CONT) 
 PRIN (NONE) 
 POST (RESU) 
 SCAL (VALU = 1.0) 
 ENTI (NAME = "TISSUE", SOLI, PROP = "mat1", SPEC = 1.0, MDIF = "C1_TISSUE") 
 ENTI (NAME = "RIGHT", PLOT) 
 ENTI (NAME = "LEFT", PLOT) 
 ENTI (NAME = "CENTER", PLOT) 
  24 ENTI (NAME = "WALL", PLOT) 
 DIFF (SET = "C1_TISSUE", CONS = 0.138380000000E-08) 
 BCNO (SPEC = 1.0, CONS = 0.137000000000E-03, ENTI = "WALL") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "RIGHT") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "LEFT") 
 BCFL (SPEC = 1.0, CONS = 0.000000000000E+00, ENTI = "CENTER") 
 ICNO (SPEC = 1.0, CONS = 0.260000000000E-03, ENTI = "TISSUE") 
 EXTR (ON, AFTE = 5, EVER = 5, ORDE = 3, NOKE, NOFR) 
END 
/  *** of FIPREP Commands 
CREATE(FIPREP,DELE) 
CREATE(FISOLV) 
PARAMETER(LIST) 
 
 
Problem Statement Keywords: 
PROB (2-D, ISOT, NOMO, TRAN, LINE, FIXE, NEWT, INCO, SPEC = 1.0) 
 
Descriptor Value  Explanation 
Geometry Type  2-D  Geometry modeled in 2-
dimensions 
Temperature Dependence  ISOTHERMAL Constant  temperature 
system 
Flow Type  NO MOMENTUM  No bulk flow 
Simulation Type  TRANSIENT  Solution is time dependent 
Convective Term  LINEAR  No convective term 
Surface Type  FIXED  Surface is fixed 
Fluid Type  NEWTONIAN  Fluid can be considered 
Newtonian 
Flow Regime  INCOMPRESSIBLE  Fluids are incompressible 
Species Dependence  SPECIES=1  Species present  
 
 
Solution Statement Keywords: 
SOLU (S.S. = 50, VELC = 0.100000000000E-02, RESC = 0.100000000000E-01, 
       SCHA = 0.000000000000E+00, ACCF = 0.000000000000E+00) 
 
Descriptor Value  Explanation 
Solution Method  Successive Substitution = 
50 
Maximum number of 
iterations  
Velocity Convergence  .1e-02  Velocity convergence 
tolerance 
Residual Convergence  .1e-1  Residual vector 
convergence tolerance 
Solution Change  0  Default percentage change 
in solution magnitude 
Relaxation Factor  ACCF = 0  For acceleration of 
convergence 
  25Time Integration Keywords: 
TIME (BACK, FIXE, TSTA = 0.000000000000E+00, TEND = 20000.0, 
       DT = 2.0, NSTE = 10000) 
 
Descriptor Value  Explanation 
Time Integration  BACKWARD  FIDAP uses implicit 
method (t + ∆t) 
Time Step Algorithm  FIXED  Time step is constant 
Start Time  0  Our problem starts at t = 0s 
End Time  20000  Our problem ends at t = 
20000s 
Time Step  2.0  Time increment is 2s 
Number of Time Steps  10000  There are 10000 fixed time 
steps 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  26The figures below shows how our solutions for the capillary preservation technique and the 
immersion preservation technique were affected the resolution of the mesh. Our final solution 
used a mesh with 399 nodes for the capillary solution as highlighted by the red circle on the 
graph and 1176 nodes for the immersion solution as shown by the red square. It is clear that at 
these levels of resolution, our solution is independent of the mesh - further refinement would not 
have any affect.  
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Mesh Convergence for Immersion Solution
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